Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction

Bookmark and Share
Sorry, this item is currently unavailable.
Published: 23 Sep 2014
Views: 2414
Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA

Dr Hutson introduces the agenda for the symposium: "Optimising metastatic renal cell carcinoma (mRCC) treatment: Lessons from the real world".

Session objectives include discussing the first-line treatment options for mRCC, assessing criteria for optimising mRCC treatment, exploring how real-world experience can inform options for first-line treatment, and discussing further development in mRCC management.

This symposium has been supported by a grant from GlaxoSmithKline.